Some studies, though not explicit, identified a germline mutation involving a known susceptibility gene for pancreatic cancer (including BRCA, ATM, CDKN2A and PALB2) in patients with familial etiology20. The gene discussed is CDKN2A; the disease is pancreatic neoplasm.